Trials / Sponsors / National Cancer Institute, Slovakia
National Cancer Institute, Slovakia
Other Government · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. Refractory Germ Cell Tumors, Dornase Alfa | Phase 2 | 2025-07-30 |
| Recruiting | Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation Hematologic Neoplasms | N/A | 2021-03-01 |
| Withdrawn | Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. Metastatic Breast Cancer | Phase 2 | 2020-01-01 |
| Completed | Disulfiram and Cisplatin in Refractory TGCTs. Germ Cell Tumor | Phase 2 | 2019-05-14 |
| Completed | Avelumab in Refractory Testicular Germ Cell Cancer. Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms | Phase 2 | 2017-11-15 |
| Completed | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer Testicular Cancer | Phase 2 | 2016-08-01 |
| Completed | First Line TIP in Poor Prognosis TGCTs. Germ Cell Tumor | Phase 2 | 2015-04-01 |
| Completed | Everolimus in Refractory Testicular Germ Cell Cancer Germ Cell Tumor | Phase 2 | 2011-11-01 |